Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (18)

2023

  1. Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?

    Cardiology, Vol. 148, Núm. 3, pp. 195-206

  2. Identifying the patient with heart failure to be treated with vericiguat

    Current Medical Research and Opinion, Vol. 39, Núm. 5, pp. 661-669

  3. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology

  4. Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization

    Expert Opinion on Pharmacotherapy, Vol. 24, Núm. 6, pp. 705-713

2022

  1. Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122

  2. Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice

    Frontiers in Pharmacology, Vol. 13

  3. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2021

  1. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2019

  1. Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 73-78

2018

  1. Incidence of hypersensitivity reactions during hemodialysis

    Kidney and Blood Pressure Research, Vol. 43, Núm. 5, pp. 1472-1478

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

2014

  1. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: Towards standard of care practices

    BMC Microbiology, Vol. 14, Núm. 1

2006

  1. Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 2, pp. 224-229

  2. Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 5, pp. 983-986